Results 141 to 150 of about 1,295 (151)

Recommended foscarnet dose is not associated with improved outcomes in cytomegalovirus salvage therapy

Journal of Clinical Virology, 2019
Michael L Spinner, Christine E Koval
exaly  

Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group

Biology of Blood and Marrow Transplantation, 2018
Nobuaki Nakano, Shinichi Kako, Yasuhiko Shibasaki   +2 more
exaly  

Tubulointerstitial nephritis caused by the antiviral agent foscarnet

Transplant International, 1989
C Svalander, I Blohmé, H Persson
exaly  

Foscarnet

Reactions Weekly, 2008
openaire   +1 more source

Stability of foscarnet sodium in 0.9% sodium chloride injection

American Journal of Hospital Pharmacy, 1994
exaly  

Foscarnet

Reactions Weekly, 1995
openaire   +1 more source

Foscarnet

Seminars in Pediatric Infectious Diseases, 1996
openaire   +1 more source

Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection

Histopathology, 1999
exaly  

Foscarnet

2006
openaire   +1 more source

Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients

Expert Review of Anti-Infective Therapy, 2012
exaly